BofA is removing BioMarin (BMRN) from its “US 1” list, which the firm says is intended to represent a collection of its best investment ideas that are drawn from the universe of Buy-rated, U.S.-listed stocks covered by BofA Global Research fundamental equity research analysts. The firm is also renewing Hilton Worldwide (HLT) following 52 weeks on the list.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on BMRN:
- Buy/Sell: Wall Street’s top 10 stock calls this week
- Netflix upgraded, Coinbase downgraded: Wall Street’s top analyst calls
- BioMarin upgraded to Outperform from Market Perform at BMO Capital
- 3 Best Stocks to Buy Now, 7/4/2023, According to Top Analysts
- BioMarin price target lowered to $110 from $120 at Guggenheim